Global Energy Based Therapeutics Market, By Product Type (Microwave, Radiofrequency, Hydro-Mechanical, Cryotherapy, Thermal and Ultrasound), Clinical Application (Aesthetic, Surgical and Ophthalmic), End-User (Hospital, Clinics and Others) – Industry Trends and Forecast to 2029.
Energy Based Therapeutics Market Analysis and Size
These therapeutics are classified into general, ophthalmic, and cosmetic surgeries based on their clinical applications. Furthermore, rising disposable incomes and a greater emphasis on maintaining an aesthetic appearance have increased demand for these medical procedures, such as facial rejuvenation, fractional laser skin resurfacing, and toxin therapy.
Data Bridge Market Research analyses that the energy based therapeutics market which was USD 6.6 billion in 2021, is expected to reach USD 12.86 billion by 2029, at a CAGR of 8.7% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Energy Based Therapeutics Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Microwave, Radiofrequency, Hydro-Mechanical, Cryotherapy, Thermal and Ultrasound), Clinical Application (Aesthetic, Surgical and Ophthalmic), End-User (Hospital, Clinics and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Johnson and Johnson Vision Care Inc (U.S.), AngioDynamics (U.S.), Alna-Medicalsystem AG and Co.KG (Germany), Alcon Vision LLC (Switzerland), ATRICURE, INC. (U.S.), Symmetry Surgical Inc. (U.S.), Boston Scientific Corporation (U.S.), biolitec AG (Germany), Cutera (U.S.), Cynosure LLC (U.S.), Dornier MedTech (Germany), INSIGHTEC (Israel), EDAP TMS (France), IRIDEX Corporation (U.S.), LIGHTMED (U.S.), Medtronic (Ireland), NIDEk CO. LTD (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Energy-based therapeutics destroy or modify tissues using technologies such as microwave, ultrasound, and radiofrequency. These therapeutics are broadly classified into general surgeries for gynaecology and lithotripsy, ophthalmic surgeries for glaucoma and cataract treatment, and aesthetic surgeries for acne and pigmentation reduction. These therapeutics, which can be both invasive and non-invasive, are rapidly gaining popularity among the general public around the world.
Global Energy Based Therapeutics Market Dynamics
Drivers
- Surging popularity of minimally-invasive surgeries
Minimally invasive surgeries have grown in popularity recently due to the shorter recovery time and lower risk associated with these procedures. Patients' preferences for minimally invasive surgeries are expected to drive demand for minimally invasive surgical instruments and energy-based therapeutics in the coming years.
Furthermore, aesthetic medicine has led to an increase in the adoption of anti-aging treatments and energy-based aesthetic surgeries, energy-based therapeutics are affordable and effective, and the global shift from invasive to non-invasive aesthetic procedures has driven market growth.
- Rising popularity of cosmetic surgeries
The rising popularity of cosmetic surgeries is one of the key factors driving market growth. In the healthcare industry, medical advances in aesthetic surgery have popularised the concept of energy-based aesthetic procedures. This is also influenced by the affordability and efficacy of the procedures, as well as the growing preference for non-invasive techniques. Furthermore, energy-based therapies such as laser and radiofrequency are used to treat menopausal genitourinary syndrome in women. These are the certain factors which helps the market to grow.
Opportunities
- Growing trend of physician-owned ambulatory surgical centres
Rising trend of physician-owned ambulatory surgical centres known as ASC’s is a key factor for the growth of the market and will create growth opportunities in energy-based therapeutics market the forecast period of 2022-2029.
Aside from that, the rising trend of ASCs or physician-owned ambulatory surgical centres is another key factor driving market growth, because the majority of energy based therapeutic procedures do not require hospitalization.
Restraints/Challenges
- Limited awareness about the diseases
High cost of products, limited awareness about the diseases, low economical condition, and lack of favourable insurance systems restricts the adoption of energy-based therapeutics products across developing regions of the globe.
This energy based therapeutics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the energy based therapeutics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Energy Based Therapeutics Market
COVID-19 had a positive impact on the market. COVID-19 is an infectious disease that has emerged as one of the leading causes of death globally, making it one of the most serious public health issues in recent decades. nCoV, the novel SARS coronavirus that causes COVID-19, has brought scientists together in search of potential therapeutic and preventive measures. The development of new drugs to effectively manage COVID-19 is a difficult and time-consuming process, so extensive research into drug repurposing and repositioning candidates is encouraged. Several medications are currently being tested in clinical trials for COVID-19, including remdesivir, hydroxychloroquine, chloroquine, lopinavir, favipiravir, ribavirin, ritonavir, interferons, azithromycin, capivasertib, and bevacizumab. In addition, several medicinal plants with considerable antiviral activities are potential therapeutic candidates for COVID-19.
Global Energy Based Therapeutics Market Scope
The energy based therapeutics market is segmented on the basis of clinical application, end-user and product type. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Microwave
- Radiofrequency
- Hydro-Mechanical
- Cryotherapy
- Thermal and Ultrasound
Clinical Application
- Aesthetic
- Surgical and Ophthalmic
End-User
- Hospital
- Clinics
- Others
Energy Based Therapeutics Market Regional Analysis/Insights
The energy based therapeutics market is analysed and market size insights and trends are provided by country, clinical application, end-user and product type as referenced above.
The countries covered in the energy based therapeutics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the energy based therapeutics market due to its well established healthcare infrastructure.
Asia-Pacific is expected to dominate in the forecast period of 2022 to 2029 owing to the rising preference for minimally invasive surgeries in this region are responsible for the growth of the market in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The energy based therapeutics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for energy based therapeutics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the energy based therapeutics market. The data is available for historic period 2010-2020.
Competitive Landscape and Energy Based Therapeutics Market Share Analysis
The energy based therapeutics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to energy based therapeutics market.
Some of the major players operating in the energy based therapeutics market are:
- Johnson and Johnson Vision Care Inc (U.S.)
- AngioDynamics (U.S.)
- Alna-Medicalsystem AG and Co.KG (Germany)
- Alcon Vision LLC (Switzerland)
- ATRICURE, INC. (U.S.)
- Symmetry Surgical Inc. (U.S.)
- Boston Scientific Corporation (U.S.)
- biolitec AG (Germany)
- Cutera (U.S.)
- Cynosure LLC (U.S.)
- Dornier MedTech (Germany)
- INSIGHTEC (Israel)
- EDAP TMS (France)
- IRIDEX Corporation (U.S.)
- LIGHTMED (U.S.)
- Medtronic (Ireland)
- NIDEk CO. LTD (U.S.)
SKU-